Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
Introduction: The T1DX-QI is a national Type 1 diabetes learning health system with thirteen endocrinology centers. The program is coordinated by the T1D Exchange in Boston, Massachusetts.
Many studies that has demonstrated the clinical benefit of Continuous Glucose Monitors (CGM) and sensors. Although favorable insurance policy changes have gradually increased the adoption of CGM devices nationally, widespread uptake has been slow.
Objective: This abstract describes how ten clinics in the T1DX-QI used QI principles including the Model for improvement including Plan – Do – Study – Act (PDSA) cycles to test and expand different initiatives in their respective centers across the United States. The interventions that were tested include the redesign of relevant workflows, assessed and removed barriers to adoption, expanding CGM educational programs.
Methods: The centers tested and reported the results of the interventions for patients in the 12–26 age cohort. The coordinating center (T1D Exchange) used Quality Improvement control and run charts rules to evaluate the effectiveness of the interventions (Figure 1 – Collaborative Wide Improvement Run Chart).
Results: Eight of ten participating centers improved their CGM uptake significantly. The increase ranged from 7% – 34%, three sites were able to improve their CGM uptake by more than 20% from baseline over the duration of the project. There was a 12% significant improvement from baseline in 20 months across the entire cohort of centers. Over 900 patients in the 12–26 years cohort were directly positively impacted by this project.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D
- Type 1 Diabetes Online Resources – September 2021by Samantha RobinsonSeptember 9, 2021
- T1D Exchange Appoints Two New Members to its Board of Directorsby Deborah TaylorSeptember 8, 2021
- Status Update: Automated Insulin Delivery Devicesby Hope WarshawSeptember 1, 2021
- Top Questions of the Day – August 2021by Sarah TackettAugust 31, 2021
- A Guide to CGMs and Medicaid Coverage Differences by Stateby Christine FallabelAugust 26, 2021